Success Metrics

Clinical Success Rate
92.0%

Based on 80 completed trials

Completion Rate
92%(80/87)
Active Trials
30(17%)
Results Posted
18%(14 trials)
Terminated
7(4%)

Phase Distribution

Ph phase_2
7
4%
Ph phase_4
19
11%
Ph not_applicable
69
39%
Ph phase_3
7
4%

Phase Distribution

0

Early Stage

7

Mid Stage

26

Late Stage

Phase Distribution102 total trials
Phase 2Efficacy & side effects
7(6.9%)
Phase 3Large-scale testing
7(6.9%)
Phase 4Post-market surveillance
19(18.6%)
N/ANon-phased studies
69(67.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

80 of 88 finished

Non-Completion Rate

9.1%

8 ended early

Currently Active

30

trials recruiting

Total Trials

175

all time

Status Distribution
Active(42)
Completed(80)
Terminated(8)
Other(45)

Detailed Status

Completed80
unknown45
Recruiting19
Not yet recruiting12
Active, not recruiting11
Terminated7

Development Timeline

Analytics

Development Status

Total Trials
175
Active
30
Success Rate
92.0%
Most Advanced
Phase 4

Trials by Phase

Phase 27 (6.9%)
Phase 37 (6.9%)
Phase 419 (18.6%)
N/A69 (67.6%)

Trials by Status

unknown4526%
completed8046%
recruiting1911%
withdrawn11%
terminated74%
not_yet_recruiting127%
active_not_recruiting116%

Recent Activity

Clinical Trials (175)

Showing 20 of 175 trialsScroll for more
NCT06853470Not Applicable

Prospective Evaluation for Receiving SynFlow 3.0 Interventional Circulatory Support in High-risk PCI: A Randomized Controlled Trial

Completed
NCT07687576Phase 2

Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study

Recruiting
NCT05807841

Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)

Recruiting
NCT07577518Not Applicable

Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome

Not Yet Recruiting
NCT07633964

An Study Looking at Percutaneous Coronary Intervention Outcomes for Octogenarians

Not Yet Recruiting
NCT07349979Not Applicable

PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF

Not Yet Recruiting
NCT07557238

CHIP-CC Registry: A Prospective Multicenter Registry of Complex High-Risk PCI in China

Not Yet Recruiting
NCT07560436Phase 2

Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

Recruiting
NCT07449052Not Applicable

Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease

Not Yet Recruiting
NCT03852082

Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention

Active Not Recruiting
NCT03971500Not Applicable

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

Active Not Recruiting
NCT07457320

Development and Validation of a Multimodal Artificial Intelligence Model for Early Prediction of Acute Myocardial Infarction

Not Yet Recruiting
NCT07444346

Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.

Not Yet Recruiting
NCT06654453Not Applicable

The Thrombus Aspiration During PCI After Thrombolysis in STEMI

Recruiting
NCT04899141

Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice

Active Not Recruiting
NCT05221931Not Applicable

Drug-Coated Balloon in Patients With High Bleeding Risk

Active Not Recruiting
NCT07405788Not Applicable

Percutaneous Coronary Intervention for Myocardial Infarction at Fujian Provincial Hospital

Active Not Recruiting
NCT04475380

Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents

Completed
NCT04894877

ISCHEMIA-EXTEND (Extended Follow-up)

Active Not Recruiting
NCT07373678

CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
175